000			01650 a2200469 4500
005			20250514194718.0
264		0	_c20040831
008			200408s 0 0 eng d
022			_a0040-6376
024	7		_a10.1136/thx.2003.019059 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, D K C
245	0	0	_aCross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. _h[electronic resource]
260			_bThorax _cAug 2004
300			_a662-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic beta-Agonists _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlbuterol _xtherapeutic use
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBronchodilator Agents _xtherapeutic use
650	0	4	_aCross-Over Studies
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Tolerance _xgenetics
650	0	4	_aEthanolamines _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aForced Expiratory Volume _xphysiology
650	0	4	_aFormoterol Fumarate
650	0	4	_aGenotype
650	0	4	_aHomozygote
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPeak Expiratory Flow Rate _xphysiology
650	0	4	_aReceptors, Adrenergic, beta-2 _xgenetics
700	1		_aJackson, C M
700	1		_aBates, C E
700	1		_aLipworth, B J
773	0		_tThorax _gvol. 59 _gno. 8 _gp. 662-7
856	4	0	_uhttps://doi.org/10.1136/thx.2003.019059 _zAvailable from publisher's website
999			_c14983795 _d14983795